News

Working Groups Seeking Online Curriculum Consultant

The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate interest and engagement in TB research advocacy. The New Tools Working Groups (WGs) are seeking an online curriculum consultant/ writer for the course. The consultant will contract with the host organization for each of the WGs. 

The overall goal of this project is to develop an online curriculum that will provide participants with a basic working knowledge and understanding of issues in TB research for vaccines, drugs, and diagnostics, even with no prior knowledge and experience with TB research. The content will consist of basics aimed at advocates, individuals from affected communities and other stakeholders interested in new tool research and development. 

An RFP for the project can be found at this link

Proposals are due Thursday, December 31st, 2020

Please address your proposal and any inquiries to: 
Jennifer Woolley 
Secretariat 
Working Group on New TB Vaccines 
wgnv@newtbvaccines.org  
 

 

More News
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...